We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2012 by Alessandra Mangia, Casa Sollievo della Sofferenza IRCCS.
Recruitment status was:  Recruiting
ClinicalTrials.gov Identifier:
First Posted: September 21, 2011
Last Update Posted: April 17, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
INMI L Spallanzani IRCCS Roma
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
Azienda Ospedaliera San Camillo Forlanini
IRCCS Policlinico S. Matteo
Azienda ospedaliera Garibaldi Nesinma Catania
Azienda Ospedaliero-Universitaria Careggi
University of Milan
Catholic University, Italy
Ospedale Francesco Ferrari
Ospedale di Canosa di Puglia
Ospedale di Venosa
Clinica Santa Rita Bari
Ospedale SS. Annunziata, Taranto
Ospedali Riuniti di Foggia
Information provided by (Responsible Party):
Alessandra Mangia, Casa Sollievo della Sofferenza IRCCS
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)